4//SEC Filing
INOVIO PHARMACEUTICALS, INC. 4
Accession 0001055726-17-000029
$INOCIK 0001055726operating
Filed
May 14, 8:00 PM ET
Accepted
May 15, 5:09 PM ET
Size
11.1 KB
Accession
0001055726-17-000029
Insider Transaction Report
Form 4
MAHMOUD ADEL
Director
Transactions
- Exercise/Conversion
Common Stock
2017-05-13+10,000→ 15,000 total - Award
Restricted Stock Unit
2017-05-12+7,669→ 7,669 total→ Common Stock (7,669 underlying) - Award
Common Stock Options
2017-05-12+12,500→ 12,500 totalExercise: $7.14From: 2018-05-12Exp: 2027-05-12→ Common Stock (12,500 underlying) - Exercise/Conversion
Restricted Stock Unit
2017-05-13−10,000→ 0 total→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018.
- [F3]Options to vest 100% on May 12, 2018.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001055726
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 5:09 PM ET
- Size
- 11.1 KB